Stay informed. See MDA updates on COVID-19

Medical Educational Resource

We're accelerating the delivery of treatments and cures.

The Champion ALS Study

Activity Snapshot

Activity Type: 
On-Demand Webinar
Release Date: 
Monday, June 1, 2020
Sponsor Information: 

This program is sponsored by Alexion. This program is not sponsored, endorsed, or accredited by MDA.

Faculty

Cori Abikoff, MD
Alexion Pharmaceuticals
The Champion ALS Study
Activity Overview: 

The CHAMPION ALS Study is a Phase 3 clinical study in Amyotrophic Lateral Sclerosis (ALS). The purpose of the study is to assess the safety and efficacy of ravulizumab-cwvzto slow the progression in adult patients with ALS with plans to recruit 354 people with ALS in multiple study centers worldwide.